{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:14:24Z","timestamp":1794266064980,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 8220101321"],"award-info":[{"award-number":["No. 8220101321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Research and Development Program of Shaanxi Province","award":["No. 2025SF-YBXM-370"],"award-info":[{"award-number":["No. 2025SF-YBXM-370"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03879-w","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T03:35:06Z","timestamp":1764473706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Active-targeting biomimetic nanosystem for prostate cancer enhances radiotherapy efficacy by inducing ferroptosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhihao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"3879_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.811044","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/fpubh.2022.811044.","journal-title":"Front Public Health"},{"key":"3879_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3879_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.clon.2019.12.007","volume":"32","author":"JR Murray","year":"2020","unstructured":"Murray JR, Roach Iii M. Role of para-aortic radiotherapy in the management of prostate cancer. Clin Oncol. 2020;32:189\u201398.","journal-title":"Clin Oncol"},{"key":"3879_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/cncr.21257","volume":"104","author":"AM Nichol","year":"2005","unstructured":"Nichol AM, Warde P, Bristow RG. Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy. Cancer. 2005;104:891\u2013905.","journal-title":"Cancer"},{"key":"3879_CR5","first-page":"437","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy\u2010associated toxicity: etiology, management, and prevention. CA Cancer J Clin. 2021;71:437\u201354.","journal-title":"CA Cancer J Clin"},{"key":"3879_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrc1950","volume":"6","author":"SM Bentzen","year":"2006","unstructured":"Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702\u201313.","journal-title":"Nat Rev Cancer"},{"key":"3879_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevOncog.2018025946","volume":"23","author":"L Chaiswing","year":"2018","unstructured":"Chaiswing L, Weiss HL, Jayswal RD, Clair DKS, Kyprianou N. Profiles of radioresistance mechanisms in prostate cancer. Crit Rev Oncogenes. 2018;23:39\u201367.","journal-title":"Crit Rev Oncogenes"},{"key":"3879_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/cncr.20093","volume":"100","author":"D Khuntia","year":"2004","unstructured":"Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA. Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1\u2013T3 prostate carcinoma in the prostate-specific antigen era. Cancer. 2004;100:1283\u201392.","journal-title":"Cancer"},{"key":"3879_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202502898","author":"Q Xu","year":"2025","unstructured":"Xu Q, Zhang M, Huang Q, Gao S, Chu S, Li Q, et al. Organic AIE nanoradiosensitizer potentiates X\u2010ray triggered continuous reactive oxygen species generation for potent cancer radioimmunotherapy. Adv Mater. 2025. https:\/\/doi.org\/10.1002\/adma.202502898.","journal-title":"Adv Mater"},{"key":"3879_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03256-7","author":"E Zeinizade","year":"2025","unstructured":"Zeinizade E, Yousefalizideh G, Aminfar P, Horn M, Ding L, Pires L, et al. Atomically-precise Au22(Lys-Cys-Lys)16 nanoclusters for radiation sensitization. J Nanobiotechnology. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03256-7.","journal-title":"J Nanobiotechnology"},{"key":"3879_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"3879_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01663-8","author":"T Luo","year":"2022","unstructured":"Luo T, Wang Y, Wang J. Ferroptosis assassinates tumor. J Nanobiotechnology. 2022. https:\/\/doi.org\/10.1186\/s12951-022-01663-8.","journal-title":"J Nanobiotechnology"},{"key":"3879_CR13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"3879_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146\u201362.","journal-title":"Cell Res"},{"key":"3879_CR15","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1021\/acsnano.8b09786","volume":"13","author":"X Zhang","year":"2019","unstructured":"Zhang X, Xi Z, Machuki JOa, Luo J, Yang D, Li J, et al. Gold cube-in-cube based oxygen nanogenerator: a theranostic nanoplatform for modulating tumor microenvironment for precise chemo-phototherapy and multimodal imaging. ACS Nano. 2019;13:5306\u201325.","journal-title":"ACS Nano"},{"key":"3879_CR16","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1021\/acsami.8b03660","volume":"10","author":"S Klein","year":"2018","unstructured":"Klein S, Harrei\u00df C, Menter C, H\u00fcmmer J, Distel LVR, Meyer K, et al. NOBF4-functionalized Au\u2013Fe3O4 nanoheterodimers for radiation therapy: synergy effect due to simultaneous reactive oxygen and nitrogen species formation. ACS Appl Mater Interfaces. 2018;10:17071\u201380.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3879_CR17","doi-asserted-by":"publisher","first-page":"15654","DOI":"10.1021\/acsnano.0c06541","volume":"14","author":"D Xia","year":"2020","unstructured":"Xia D, Hang D, Li Y, Jiang W, Zhu J, Ding Y, et al. Au\u2013hemoglobin loaded platelet alleviating tumor hypoxia and enhancing the radiotherapy effect with low-dose X-ray. ACS Nano. 2020;14:15654\u201368.","journal-title":"ACS Nano"},{"key":"3879_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton JK, Furst L, Ruberto RA, Moosmayer D, Hilpmann A, Ryan MJ, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16:497\u2013506.","journal-title":"Nat Chem Biol"},{"key":"3879_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine\/glutamate antiporter system xc\u2212in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"3879_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nmat2608","volume":"9","author":"P Horcajada","year":"2009","unstructured":"Horcajada P, Chalati T, Serre C, Gillet B, Sebrie C, Baati T, et al. Porous metal\u2013organic-framework nanoscale carriers as a potential platform for drug delivery\u00a0and imaging. Nat Mater. 2009;9:172\u20138.","journal-title":"Nat Mater"},{"key":"3879_CR21","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1021\/acsnano.8b00932","volume":"12","author":"R Freund","year":"2018","unstructured":"Freund R, L\u00e4chelt U, Gruber T, R\u00fchle B, Wuttke S. Multifunctional efficiency: extending the concept of atom economy to functional nanomaterials. ACS Nano. 2018;12:2094\u2013105.","journal-title":"ACS Nano"},{"key":"3879_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41585-019-0272-5","volume":"17","author":"S Siva","year":"2020","unstructured":"Siva S, Udovicich C, Tran B, Zargar H, Murphy DG, Hofman MS. Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer. Nat Rev Urol. 2020;17:107\u201318.","journal-title":"Nat Rev Urol"},{"key":"3879_CR23","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/0008-5472.CAN-20-1624","volume":"81","author":"J Matthias","year":"2021","unstructured":"Matthias J, Engelhardt J, Sch\u00e4fer M, Bauder-W\u00fcst U, Meyer PT, Haberkorn U, et al. Cytoplasmic localization of prostate-specific membrane antigen inhibitors may confer advantages for targeted cancer therapies. Cancer Res. 2021;81:2234\u201345.","journal-title":"Cancer Res"},{"key":"3879_CR24","doi-asserted-by":"publisher","first-page":"59471","DOI":"10.18632\/oncotarget.10697","volume":"7","author":"D Han","year":"2016","unstructured":"Han D, Wu J, Han Y, Wei M, Han S, Lin R, et al. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer. Oncotarget. 2016;7:59471\u201381.","journal-title":"Oncotarget"},{"key":"3879_CR25","first-page":"4055","volume":"58","author":"He Liu","year":"1998","unstructured":"Liu He, Peggy Moy AKR, Xia Y, Kim S, Navarro V, Rahmati R, et al. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res. 1998;58:4055\u201360.","journal-title":"Cancer Res"},{"key":"3879_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"3879_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"J Dixon Scott","year":"2012","unstructured":"Dixon Scott J, Lemberg Kathryn M, Lamprecht Michael R, Skouta R, Zaitsev Eleina M, Gleason Caroline E, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"3879_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"3879_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"3879_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-29905-1.","journal-title":"Nat Commun"},{"key":"3879_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102677","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang H-L, Li J, Ye Z-P, Du T, Li L-C, et al. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biol. 2023. https:\/\/doi.org\/10.1016\/j.redox.2023.102677.","journal-title":"Redox Biol"},{"key":"3879_CR32","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.7150\/thno.75837","volume":"12","author":"Z Yang","year":"2022","unstructured":"Yang Z, Qiao C, Jia Q, Chen Z, Wang X, Liu X, et al. Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy. Theranostics. 2022;12:6143\u201354.","journal-title":"Theranostics"},{"key":"3879_CR33","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1002\/anie.201902612","volume":"58","author":"Z He","year":"2019","unstructured":"He Z, Huang X, Wang C, Li X, Liu Y, Zhou Z, et al. A catalase\u2010like metal\u2010organic framework nanohybrid for O 2 \u2010evolving synergistic chemoradiotherapy. Angew Chem Int Ed. 2019;58:8752\u20136.","journal-title":"Angew Chem Int Ed"},{"key":"3879_CR34","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.7150\/thno.25179","volume":"8","author":"X Huang","year":"2018","unstructured":"Huang X, He Z, Guo D, Liu Y, Song J, Yung BC, et al. \u201cThree-in-one\u201d nanohybrids as synergistic nanoquenchers to enhance no-wash fluorescence biosensors for ratiometric detection of cancer biomarkers. Theranostics. 2018;8:3461\u201373.","journal-title":"Theranostics"},{"key":"3879_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","volume":"530","author":"J Kang","year":"2022","unstructured":"Kang J, La Manna F, Bonollo F, Sampson N, Alberts IL, Mingels C, et al. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Lett. 2022;530:156\u201369.","journal-title":"Cancer Lett"},{"key":"3879_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pros.22742","volume":"74","author":"G Gandaglia","year":"2013","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat SF, Kim SP, et al. Distribution of metastatic sites in patients with prostate cancer: a population\u2010based analysis. Prostate. 2013;74:210\u20136.","journal-title":"Prostate"},{"key":"3879_CR37","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.1697","volume":"7","author":"M Riihim\u00e4ki","year":"2018","unstructured":"Riihim\u00e4ki M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Clinical landscape of cancer metastases. Cancer Med. 2018;7:5534\u201342.","journal-title":"Cancer Med"},{"key":"3879_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.597673","author":"A Mal","year":"2021","unstructured":"Mal A, Bukhari AB, Singh RK, Kapoor A, Barai A, Deshpande I, et al. EpCAM-mediated cellular plasticity promotes radiation resistance and metastasis in breast cancer. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2020.597673.","journal-title":"Front Cell Dev Biol"},{"key":"3879_CR39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/hep.32177","volume":"75","author":"Y Fang","year":"2021","unstructured":"Fang Y, Zhan Y, Xie Y, Du S, Chen Y, Zeng Z, et al. Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC. Hepatology. 2021;75:1386\u2013401.","journal-title":"Hepatology"},{"key":"3879_CR40","doi-asserted-by":"publisher","first-page":"9524","DOI":"10.1039\/D4TB01747A","volume":"12","author":"SL Mekuria","year":"2024","unstructured":"Mekuria SL, Li G, Wang Z, Girma WM, Li A, He M, et al. Dendrimer nanoclusters loaded with gold nanoparticles for enhanced tumor CT imaging and chemotherapy via an amplified EPR effect. J Mater Chem B. 2024;12:9524\u201332.","journal-title":"J Mater Chem B"},{"key":"3879_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02414-7","author":"J Jiang","year":"2024","unstructured":"Jiang J, Lu Y, Chu J, Zhang X, Xu C, Liu S, et al. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases. J Nanobiotechnology. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02414-7.","journal-title":"J Nanobiotechnology"},{"key":"3879_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.03.081","volume":"487","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Badkas A, Stevenson M, Lee J-Y, Leung Y-K. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery. Int J Pharm. 2015;487:81\u201390.","journal-title":"Int J Pharm"},{"key":"3879_CR43","doi-asserted-by":"publisher","first-page":"68437","DOI":"10.1021\/acsami.4c16504","volume":"16","author":"W Liu","year":"2024","unstructured":"Liu W, Nie F, Jiang H, Zhao Y, Zhang Y, Zhang Z, et al. Preparation of pH-sensitive polysaccharide-small molecule nanoparticles and their applications for tumor chemo- and immunotherapy. ACS Appl Mater Interfaces. 2024;16:68437\u201352.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3879_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195637","author":"L King","year":"2022","unstructured":"King L, Bernaitis N, Christie D, Chess-Williams R, Sellers D, McDermott C, et al. Drivers of radioresistance in prostate cancer. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11195637.","journal-title":"J Clin Med"},{"key":"3879_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2022.135309","author":"Y Liang","year":"2022","unstructured":"Liang Y, Peng C, Su N, Li Q, Chen S, Wu D, et al. Tumor microenvironments self-activated cascade catalytic nanoscale metal organic frameworks as ferroptosis inducer for radiosensitization. Chem Eng J. 2022. https:\/\/doi.org\/10.1016\/j.cej.2022.135309.","journal-title":"Chem Eng J"},{"key":"3879_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121527","author":"U Hani","year":"2024","unstructured":"Hani U, Choudhary VT, Ghazwani M, Alghazwani Y, Osmani RAM, Kulkarni GS, et al. Nanocarriers for delivery of anticancer drugs: current developments, challenges, and perspectives. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16121527.","journal-title":"Pharmaceutics"},{"key":"3879_CR47","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.scib.2021.02.026","volume":"66","author":"S Xu","year":"2021","unstructured":"Xu S, Min J, Wang F. Ferroptosis: an emerging player in immune cells. Sci Bull. 2021;66:2257\u201360.","journal-title":"Sci Bull"},{"key":"3879_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02166-1","author":"X Li","year":"2024","unstructured":"Li X, Yang G, Ma L, Tang B, Tao T. N6-methyladenosine (m6A) writer METTL5 represses the ferroptosis and antitumor immunity of gastric cancer. Cell Death Discov. 2024. https:\/\/doi.org\/10.1038\/s41420-024-02166-1.","journal-title":"Cell Death Discov"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03879-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03879-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03879-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:15:56Z","timestamp":1767633356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03879-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03879-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}